CARATELLI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.480
EU - Europa 180
AS - Asia 68
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 1.735
Nazione #
US - Stati Uniti d'America 1.477
SG - Singapore 38
IT - Italia 32
PL - Polonia 26
IE - Irlanda 25
DE - Germania 20
CN - Cina 19
UA - Ucraina 18
GB - Regno Unito 14
FR - Francia 13
RU - Federazione Russa 13
FI - Finlandia 6
SE - Svezia 6
KR - Corea 4
NL - Olanda 4
AU - Australia 3
CA - Canada 3
EU - Europa 2
KG - Kirghizistan 2
PH - Filippine 2
RO - Romania 2
BA - Bosnia-Erzegovina 1
BR - Brasile 1
IR - Iran 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
UZ - Uzbekistan 1
Totale 1.735
Città #
Woodbridge 359
Houston 358
Wilmington 322
Fairfield 70
Chandler 56
Ashburn 44
Seattle 38
Singapore 37
Cambridge 26
Kraków 26
Ann Arbor 24
Dublin 18
New York 16
Dearborn 13
Jacksonville 13
Rome 13
Medford 11
Santa Clara 9
San Diego 6
Zhengzhou 6
Boardman 5
Lawrence 5
London 4
Redwood City 4
Centrale 3
Falls Church 3
Helsinki 3
Menlo Park 3
Milan 3
Norwalk 3
Beijing 2
Columbus 2
Frankfurt am Main 2
Hackensack 2
Hull 2
Lecce 2
Monte Vista 2
Moscow 2
Munich 2
Renton 2
Rockdale 2
Roebling 2
Shanghai 2
Shenyang 2
Washington 2
Ardabil 1
Ariccia 1
Baltimore 1
Bari 1
Billerica 1
Brisbane 1
Casalnuovo Di Napoli 1
Changsha 1
Chapel Hill 1
Cluj-napoca 1
Cornaredo 1
Islington 1
Jinan 1
Los Angeles 1
Manila 1
Nanjing 1
Newark 1
Ningbo 1
Palo Alto 1
Quezon City 1
Rosmalen 1
San Francisco 1
Sarajevo 1
Seoul 1
Shaoxing 1
St. George 1
Toronto 1
Utrecht 1
Yellow Springs 1
Totale 1.560
Nome #
Peroxiredoxin 6, a novel player in the pathogenesis of diabetes 530
Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia 394
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker 364
In vitro elimination of EGFR-overexpressing cancer cells by CD32A chimeric receptor T cells in combination with cetuximab or panitumumab 270
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab 165
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment 41
EGFR+ Glioblastoma stem cells targeting by CD16158V-chimeric receptor T cells and cetuximab 19
Totale 1.783
Categoria #
all - tutte 4.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020382 0 0 0 0 38 82 59 54 50 41 31 27
2020/2021302 23 25 27 63 31 23 29 34 25 8 9 5
2021/202266 2 2 2 2 4 9 3 8 2 10 3 19
2022/2023127 7 10 7 26 13 20 13 10 15 0 3 3
2023/202478 7 3 3 2 1 32 11 4 4 1 1 9
2024/202582 9 36 16 16 5 0 0 0 0 0 0 0
Totale 1.783